INTRODUCTION
Various types of enterovirus are disseminated every summer in communities of the temperate zone, causing outbreaks of different clinical types of illness, particularly among infants and children. In the summer of 1971 unusual prevalence of aseptic meningitis was noted throughout Japan; echovirus type 11 (E-11) was found to have played the main role. It was also noticed that a number of newborn babies and infants under 6 months of age were involved, despite the rule that these age groups are usually exempted from illness because of the passage of immunity from the mothers. In the epidemic areas E-11 was recovered from adults, hence it was suspected that pregnant women might have been infected with E-11 and thus its passage via placenta to babies might have happened.
This report describes the results of studies focused on perinatal E-11 infections breaking out during July and August, 1971 , in a maternity unit of K Hospital in Tokyo.
MATERIALS AND METHODS
Specimens for virus isolation: Stool specimens and throat swabs were collected from 14 infants having fever and stomatitis. They were born between mid July and the end of September, 1971, at K Hospital in Tokyo. All the specimens were stored at -20 C in a freezer before use.
Patient's sera: Acute and convalescent phase sera were obtained from the babies described above. At the same time 11 mothers were bled when the acute sera were collected from their babies. As controls, sera were collected from healthy infants who were born at the same hospital during the same period and those of their mothers.
Cell cultures: Primary cynomolgus monkey kidney (MK) and human embryonic lung (HEL) cell cultures were mainly used. MK and HEL cells were grown in lactalbumin-Earle (LE) medium plus 2% bovine serum and Eagle's MEM plus 10% calf serum, respectively. MK cells were maintained in LE medium without serum and HEL cells in Eagle's MEM plus 2% calf serum.
Virus isolation and identification: MK and HEL tube cultures were inoculated with 0.2 to 1-ml amounts of properly diluted materials: 10% stool suspensions and throat swabs. All cultures were incubated at 37 C for 7 days. Three blind passages were performed before they were considered negative. Cultures having shown cytopathic effects (CPE) were usually passaged at least once to increase the infectivity titer before identification tests. The isolates were identified by the neutralization test.
Fractionation o f 19S and 7S antibodies: A 0.4-ml amount of a serum specimen, diluted 1:4, was layered on 4 ml of 12.5 to 37% (w/v) sucrose-PBS gradient and centrifuged at 35,000 rpm for 16 hr at 5 C in a Spinco SW 39 rotor. After centrifugation, fractions were collected from the bottom of the tubes.
Serologic tests: (a) Neutralization test (NT) using tube cultures: Serial dilutions of serum, inactivated at 56 C for 30 min, were mixed with equal quantities of a virus suspension containing about 100 TCD50 per 0.1 ml. After incubation at 37 C for 3 hr, 0.2 ml of the mixture was inoculated into each of two HEL cellculture tubes. The cultures were incubated at 37 C; CPE was read and recorded 4 days postinoculation. (b) Plaque reduction neutralization test (modified by Tagaya, 1964) : Serial twofold dilutions of immune sera or fractionated patients' sera were mixed with about 100 PFU of virus per 0.1 ml. The mixture was incubated for 2 hr at 37 C and 0.2 ml of the serum-virus mixture was inoculated onto HEL cell monolayers in 60-mm plastic dishes (Falcon). After an adsorption period of one hour at 37 C, the monolayers were covered with 0.9% agarose in 199 medium enriched with 2% calf serum and 0.15% sodium bicarbonate. A second overlay medium containing neutral red in a final dilution of 1:60,000 was added to the culture 2 to 4 days postinoculation. injection. The first injection was made intramuscularly; the second and the third were subcutaneously. The antigen used was MK cell-culture fluid centrifuged at 10,000 rpm for 30 min and then treated with fluorocarbon, whose infectivity was about 108 TCD50 per ml.
RESULTS

An Outbreak of Echovirus Type 11 Infection in a Maternity Unit
Between 21 July and 9 October 1971, 41 newborn babies at K Hospital in Tokyo developed symptoms: 31 cases had pyrexia; other four with stomatitis; and the other six with fever and stomatitis. Since 188 babies were born during the above period, the attack rate was about 22%. The ages of newborns at the onset of disease ranged from 3 to 21 days after birth. The incidence of infection was the highest in August, the number of patients being 32.
Fecal and throat-swab specimens were obtained for virus isolation from 14 of those 41 infants. CPE agents were recovered from stool of the 14 babies and from two throat swabs. They were not neutralized with intersecting pools of antienterovirus sera, but the immune guinea-pig sera against the YC-71-106 strain neutralized both the homologous strain and the prototype Gregory strain; their neutralizing antibody titers were 1:1280 and 1:640, respectively. Therefore, those 16 CPE agents were identified as E-11 together with the following results of serologic tests with paired patients' sera shown in Table I . Nineteen pairs of acute and convalescent sera were assayed for antibody rise to the isolate, YC-71-106 strain, in HEL cell tube cultures. Four-fold or more rises of neutralizing antibody titers were found with 15 paired sera (79%). In the other 4 patients, acute sera already showed high titers of neutralizing antibody. Similar results were obtained with prototype Gregory strain as antigen. Twelve of these 19 paired sera were from the newborns, from whose feces E-11 was isolated. Seven of 11 mothers' sera had no neutralizing antibody (less than 1:4) against the current strain, and five of them had no antibody to the Gregory strain either. It is peculiar that about half of mothers had no detectable antibody to either the epidemic or the prototype E-11 strain.
NT was carried out with control sera collected during the same epidemic period from 12 healthy infants and their mothers. Ten of the 12 pairs of infants' and mothers' sera had titers less than 1:4, and the other two had 1:8 and 1:64. In HI tests, four fold or greater HI-antibody rises were shown in 10 of the 15 babies; their antibody titers were higher with the current strain than with the prototype strain. Firstly, HI-antibody titers against E-11 were tested on four kaolin treated and untreated sera to determine for nonspecific hemagglutinin inhibitors . In two sera which had no NT antibody, the HI activity detected in the top fractions (fractions No. 10 and above) was considered to have been due to nonspecific inhibitors , because they were removed completely by the kaolin treatment. On the other hand, two sera which had NT antibody showed two peaks of HI activity even after the kaolin treatment. But the peaks were smaller than those of untreated one, suggesting some adsorption of antibody to kaolin. Therefore, subsequent HI tests were performed on untreated sera; hemolysin was determined as a marker to locate 19S and 7S antibodies. The results obtained are shown in Fig . 1 .
HI antibody activity to E-11 was detected in the 19S fractions of convalescent sera (I-B & II-B), but not in acute phase sera of the infants (I-A & II-A) . These infants were confirmed to have been infected with E-11 by both virus isolation and NT. Similarly, one mother was infected with E-11 at the same time as the baby was, as convalescent serum from the mother (I-D) had detectable HI antibody . The HI activity found in fractions No. 11 and above in these acute phase sera antibodies, although the 7S fractions contained some HI activity due to nonspecific inhibitors.
To determine whether the 7S fractions with low HI antibody titers as mentioned above had neutralizing activities or not, plaque reduction neutralization tests were performed. Three fractions from the peak of 19S and that of 7S positions located in reference to the hemolysin titers were pooled and each pool was diluted 1:10. Serial twofold dilutions of these materials were mixed with equal volumes of virus (100 PFU/0.1 ml), the prototype strain and the current strain (YC-71-321) of E-11. The results obtained are summarized in Table IV . The 7S and 19S antibodies to E-11 were found in convalescent sera from all affected infants . Two acute phase sera (III & IV) contained 19S antibody, and moreover one serum (IV) had 7S antibody. It was considered that the infant must have produced 7S antibody within 7 days after delivery, since his mother had no detectable antibodies . The neonatal immune response was more predominant in 19S than in 7S antibody . There was a distinct difference in antibody titers between the prototype and the epidemic strain of E-11. In the 19S fractions, antibodies against both strains were detected, but titers of the antibody to the prototype strain was lower, being approximately one-fourth to one-fifth of those to the current strain. The 7S fractions , on the other hand, usually contained antibody to the current strain only and had titers lower than 1:10 against the prototype strain. The E-11 infection in mothers was suggested by the fact that two convalescent sera (I & V) from mothers had both 19S and 7S antibodies. (Berkovich and Kibrick, 1964; Lapinleimu, 1971; Cramblett et al ., 1973) .
The data in Table  I 
